BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35330518)

  • 1. Evaluation of the Preoperative Haematological Parameters Predicting the High T-Stage and Fuhrman Grade in Renal Cell Carcinoma.
    Oner I; Sackan F; Ozdemir D
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):461-466. PubMed ID: 35330518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
    Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
    J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
    Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
    Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Preoperative Neutrophil - to - Lymphocyte Ratio in Renal Cell Carcinoma.
    Otunctemur A; Dursun M; Besiroglu H; Ozer K; Horsanali O; Ozbek E
    Int Braz J Urol; 2016; 42(4):678-84. PubMed ID: 27564277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Peritumor and Intratumor Vascularity on Preoperative Imaging to Predict Fuhrman Grade Histology of Renal Tumors.
    Ghiraldi EM; Nguyen J; Buck M; Nair H; Israel G; Singh D
    J Endourol; 2022 Nov; 36(11):1489-1494. PubMed ID: 35670255
    [No Abstract]   [Full Text] [Related]  

  • 8. Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.
    Zhang ZL; Chen W; Li YH; Liu ZW; Luo JH; Lau W; Tan MH; Zhou FJ
    Chin J Cancer; 2011 Nov; 30(11):772-8. PubMed ID: 22035858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
    Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Hematological Parameters in Predicting Fuhrman Grade and Tumor Stage in Renal Cell Carcinoma Patients Undergoing Nephrectomy.
    Kisa E; Yucel C; Keskin MZ; Karabicak M; Yalcin MY; Cakmak O; Ilbey YO
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216752
    [No Abstract]   [Full Text] [Related]  

  • 12. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
    Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma.
    Lee A; Lee HJ; Huang HH; Tay KJ; Lee LS; Sim SPA; Ho SSH; Yuen SPJ; Chen K
    Clin Genitourin Cancer; 2020 Aug; 18(4):304-313. PubMed ID: 31892491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence risk groups after nephrectomy for renal cell carcinoma.
    Polanco Pujol L; Herranz Amo F; Caño Velasco J; Subirá Ríos D; Moralejo Gárate M; Hernández Cavieres J; Barbas Bernardos G; Bueno Chomón G; Rodríguez Fernández E; Hernández Fernández C
    Actas Urol Esp (Engl Ed); 2020 Mar; 44(2):111-118. PubMed ID: 31836313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinicopathological features and prognosis in 68 patients with chromophobe renal cell carcinoma].
    Huang JW; Zhang J; Dong BJ; Kong W; Niu SX; Chen YH; Xue W; Liu DM; Huang YR
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):510-3. PubMed ID: 22967469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
    Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.